Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
biochemical pharmacology; biomarkers; biosynthetics; chromosome; DNA structure; epigenetics; genetics; genomics; histology; individually tailored therapy; medicinal chemistry; medicine; membrane proteins; membrane transport; molecular biology; molecular pharmacology; pathophysiology; pharmacy; physiology; population genetics; proteomics; RNA structure; signal transduction; stem cells; transcriptional analyses; transgenic techniques; translational analyses
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Drug Delivery Systems: From Nanoparticles to Precision Medicine (Deadline: 30 December 2025)
- Biomedical Applications of Mesenchymal Stem Cells (Deadline: 30 December 2025)
- Gene-Level Pharmacological Research on Natural Products (Deadline: 30 December 2025)
- Molecular Insight into Antimicrobial Resistance (Deadline: 30 December 2025)
- The Impact of Natural Bioactive Compounds on Human Health and Disease (Deadline: 31 December 2025)
- Natural Products in Drug Discovery and Development (Deadline: 31 December 2025)
- Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis, 3rd Edition (Deadline: 31 December 2025)
- Synthesis and Structural Studies of Potential Anticancer Drugs (Deadline: 31 December 2025)
- Advances in Drug Synthesis Reactions: From Bench to Breakthroughs (Deadline: 31 December 2025)
- 25th Anniversary of IJMS: Updates and Advances in Molecular Pharmacology (Deadline: 31 December 2025)
- Pharmacological Agents for Soft Tissue and Articular Injections: From Mechanisms to Clinical Applications (Deadline: 31 December 2025)
- Advances in Pharmacology for Neuropathic and Chronic Pain Management (Deadline: 31 December 2025)
- Targeted Pharmacological Modulation of Cellular Pathology and Drug Discovery: A Translational Approach to Bridge Laboratory Discoveries with Clinical Practice (Deadline: 31 December 2025)
- Cell Penetrating Peptides: Novel Therapeutic Tools for Drug Delivery (Deadline: 31 December 2025)
- Natural-Derived Bioactive Compounds in Disease Treatment (Deadline: 20 January 2026)
- Recent Advances of Novel Pharmaceutical Designs for Anti-Cancer Therapies, 3rd Edition (Deadline: 20 January 2026)
- Advances in Drug Discovery and Synthesis: 2nd Edition (Deadline: 20 January 2026)
- Drug Discovery and Development for Renal Disease Treatment (Deadline: 20 January 2026)
- Drug Delivery Systems and Treatment of Human Diseases: Prospects and Challenges (Deadline: 20 January 2026)
- Advances and Emerging Trends in Marine Natural Products (Deadline: 20 January 2026)
- Innovative Strategies in the Design and Development of Anticancer Agents (Deadline: 20 January 2026)
- Molecular Advances in Liposome-Based Drug Delivery Systems (Deadline: 30 January 2026)
- Mechanistic and Small Molecule Discoveries for Therapeutic Advances in Hypertrophic and Dilated Cardiomyopathies (Deadline: 30 January 2026)
- Drug Development Breakthroughs: From Novel Antimicrobials to Targeted Cancer Drugs (Deadline: 30 January 2026)
- New Progress in Peptide Drugs (Deadline: 31 January 2026)
- Natural Products and Compounds in Anticancer Drug Discovery (Deadline: 31 January 2026)
- Ion Channels as Therapeutic Target: Drug Design and Pharmacological Investigation (3rd Edition) (Deadline: 31 January 2026)
- The Medicinal Value of Plant Extracts (Deadline: 31 January 2026)
- Emerging Strategies in Tuberculosis Drug Discovery (Deadline: 31 January 2026)
- Antibody Engineering and Therapeutic Applications (Deadline: 31 January 2026)
- Breaking Barriers in Drug Discovery: Novel Methodologies and Mechanisms of Action (Deadline: 31 January 2026)
- Small Molecules and Antibodies for Targeted Cancer Therapies (Deadline: 31 January 2026)
- Molecular Pharmacognosy: Bioactive Natural Products and Mechanistic Insights (Deadline: 31 January 2026)
- Molecular Pharmacology of Medicinal Plants (Deadline: 20 February 2026)
- Biocatalysis of Compounds for Pharmaceutical and Biomedical Applications (Deadline: 20 February 2026)
- Drug Therapy of Systemic Lupus Erythematosus (Deadline: 20 February 2026)
- Antimicrobial Resistology: A New Approach in the Fight Against Antimicrobial Resistance (Deadline: 20 February 2026)
- Drugs—from Chemical Structure to Biological Activity (Deadline: 20 February 2026)
- Biosynthesis of Phytochemicals and Their Applications in Novel Drug Lead Development (Deadline: 20 February 2026)
- Angiotensin II in Cardiac Fibrosis and Heart Failure (Deadline: 25 February 2026)
- Drug Discovery Based on Natural Products (Deadline: 28 February 2026)
- Anti-Cancer Drugs: Natural Products, Synthetic Compounds and Potential Pharmacological Effects and Applications (Deadline: 28 February 2026)
- Molecular Strategies for the Discovery, Optimization, and Efficient Use of Green Pesticides (Deadline: 28 February 2026)
- Exploring Melatonin and Related Indolic Agents (Deadline: 28 February 2026)
- Network Pharmacology: An Emerging Field in Drug Discovery (2nd Edition) (Deadline: 28 February 2026)
- New Insights into Network Pharmacology (Deadline: 28 February 2026)
- Cardiovascular and Metabolic Pharmacology (Deadline: 28 February 2026)
- Advances in Anticancer Drug Discovery: Design, Synthesis and Molecular Insights (Deadline: 28 February 2026)
- Next-Generation Drug Development: Novel Modalities, AI Modeling, and Biomarkers (Deadline: 28 February 2026)
- Role of Natural Products in Health and Diseases (Deadline: 15 March 2026)
- Antiviral Drugs Discovery (Deadline: 20 March 2026)
- Drug Discovery and Development Focusing on Natural Products (Deadline: 20 March 2026)
- The Role of Natural Products in Inflammation (Deadline: 20 March 2026)
- Mechanistic Insights into Pharmacological and Non-Pharmacological Pain Therapies: From Cellular Responses to Therapy Outcomes (Deadline: 20 March 2026)
- Molecular Pharmacology of Protein Kinase Inhibitor (Deadline: 20 March 2026)
- Drug Discovery: Natural Products and Compounds (Deadline: 20 March 2026)
- Metallopharmaceuticals: Current Trends and Future Perspectives in Cancer Immunoediting (Deadline: 30 March 2026)
- Antitumoral Properties of Natural and Synthetic Compounds (Deadline: 30 March 2026)
- Molecular Advances on Cannabinoid and Endocannabinoid Research, 3rd Edition (Deadline: 31 March 2026)
- Pharmacological Approaches in Inflammation, Aging, and Cardiovascular Diseases (Deadline: 31 March 2026)
- Advances in Drug Discovery: Emerging Radiotracers and Small Molecule Inhibitors for Cancer and Neurological Disorders (Deadline: 31 March 2026)
- PPAR Update: Molecular Mechanisms and Therapeutic Perspectives (Deadline: 31 March 2026)
- Emerging Horizons of Innovations, Mechanisms, and Translational Prospects of Chitosan-Based Drug Delivery Therapeutic Interventions (Deadline: 31 March 2026)
- Research on Drug Delivery in Health and Disease (Deadline: 10 April 2026)
- Small Molecule Drug Design and Research: 3rd Edition (Deadline: 20 April 2026)
- Research and Recent Advances of Antimicrobials (Deadline: 20 April 2026)
- Nose-to-Brain Drug Delivery: Opportunities and Challenges (Deadline: 20 April 2026)
- Newer Pharmacological Treatment Concepts for Patients with Acute Coronary Syndrome (Deadline: 20 April 2026)
- Novel Approaches in Drug Discovery: From Natural Products to Therapeutic Innovations (Deadline: 20 April 2026)
- Synthetic Chemistry in Drug Discovery (Deadline: 20 April 2026)
- Peptide and Protein Drugs Against Infectious Diseases and Allergic Diseases (Deadline: 20 April 2026)
- Techniques and Strategies in Drug Design and Discovery, 3rd Edition (Deadline: 20 April 2026)
- New Advances in Reversing Cancer Therapy Resistance (Deadline: 20 April 2026)
- Advancements in Antioxidant Molecules: From Discovery to Therapeutic Applications (Deadline: 20 April 2026)
- Antimicrobial Agents and the Quest for Resistance Breakthroughs (Deadline: 20 April 2026)
- 3D Printing in Pharmaceutical Drug Delivery (Deadline: 20 April 2026)
- Advances in Photodiagnosis and Photodynamic Therapy (Deadline: 20 April 2026)
- Phytochemicals for Diabetes (Deadline: 30 April 2026)
- Preservation of Testicular Function: From Andrological Pathologies to Testis Cancer (Deadline: 30 April 2026)
- Multi-Target and Synergistic Therapeutic Strategies in Modern Drug Discovery (Deadline: 30 April 2026)
- Application of Natural Products in Biomedicine and Pharmacotherapy: 3rd Edition (Deadline: 30 April 2026)
- Natural Compounds in Cancer Therapy and Prevention, 2nd Edition (Deadline: 20 May 2026)
- Antituberculous Drugs: Progress and Challenges (Deadline: 20 May 2026)
- New Anti-cancer Agents: Design, Synthesis and Applications (Deadline: 20 May 2026)
- Molecular Pharmacological Advances in Gastrointestinal Health (Deadline: 20 May 2026)
- Pharmacology and Toxicology of Synthetic and Natural Products (Deadline: 20 May 2026)
- New Advances in Opioid Research (Deadline: 20 May 2026)
- Molecular Research on Potential New Antidepressant Drugs (Deadline: 20 May 2026)
- New Insights in Artificial Intelligence for Drug Design and Target Discovery (Deadline: 20 May 2026)
- Advances in Organic Synthesis in Drug Discovery (Deadline: 20 May 2026)
- From Nature to Medicine: Exploring Natural Products for New Therapies (Deadline: 20 May 2026)
- Molecular Pharmacology of Cation-Permeable Ion Channels (Deadline: 20 May 2026)
- Structural Characterization and Pharmacological Activity of Natural Compounds (Deadline: 20 May 2026)
- Targeted Protein Degradation: From Molecular Mechanisms to Therapeutic Applications (Deadline: 20 May 2026)
- New Insights into Chemotherapeutic Agents in Cancer Treatment (Deadline: 20 May 2026)
- Antiviral Drug Targets: Structure, Function, and Drug Design—3rd Edition (Deadline: 20 May 2026)
- Molecular Computational Research in Pharmacological Structure–Efficacy (Deadline: 20 May 2026)
- Enzyme Inhibitory Assessment and Molecular Docking Studies of Natural and Synthetic Heterocyclic Compounds (Deadline: 20 May 2026)
- Design, Synthesis, and Biological Evaluation of Novel Bioactive Compounds (Deadline: 30 May 2026)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity, 3rd Edition (Deadline: 31 May 2026)
- The Future of Drug Discovery and Development, 2nd Edition (Deadline: 31 May 2026)
- Advances in the Pharmacology of Depression and Mood Disorders (Deadline: 31 May 2026)
- Curcumin Derivatives and Curcuminoids with Potential Biomedical Applications (Deadline: 31 May 2026)
- Drug Treatment for Bacterial Infections: 2nd Edition (Deadline: 31 May 2026)
- Synthesis and Activity Studies of Anticancer Compounds (Deadline: 31 May 2026)
- Advancements in Diagnostic and Preventive Pharmacogenomics (Deadline: 20 June 2026)
- Natural Products and Synthetic Compounds for Drug Development: 3rd Edition (Deadline: 20 June 2026)
- Pharmacokinetics of Psychoactive Substances: Molecular and Forensic Aspects (Deadline: 20 June 2026)
- Glycoconjugates: From Structure to Therapeutic Application (Deadline: 20 June 2026)
- The Role of Bioactive Natural Products in Human Health (Deadline: 20 June 2026)
- Natural Bioactive Compounds for Human Health, 3rd Edition (Deadline: 20 June 2026)
- Recent Advances in Computer-Aided Drug Design (Deadline: 20 June 2026)
- Molecular Modeling in Pharmaceutical Sciences (Deadline: 20 June 2026)
- Anticancer Drugs: Current Status and Future Directions (Deadline: 20 June 2026)
- Anti-Cancer Effects of Natural Products: 2nd Edition (Deadline: 20 June 2026)
- Molecular Discoveries in Pharmacogenetics: From Bench to Bedside (Deadline: 30 June 2026)
- From Drug Design to Mechanistic Understanding and Resistance (Deadline: 30 June 2026)
- The Role of Natural Products in Drug Discovery: 2nd Edition (Deadline: 30 June 2026)
- G Protein-Coupled Receptors: Signaling, Regulation and Therapeutic Opportunities, 2nd Edition (Deadline: 20 July 2026)
- In Silico Approaches to Unravelling Toxicity Mechanisms in Molecular Drugs (Deadline: 20 July 2026)
- Natural Products for Cancer: Cutting-Edge Trends and Future Directions (Deadline: 30 July 2026)
- Lipopolysaccharide as a Drug Target (Deadline: 20 August 2026)
- Latest Advances in Antiparasitic Agents (Deadline: 30 August 2026)
- Advanced Research in Veterinary Drugs (Deadline: 20 September 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
